Dietary Supplement Regulatory Uniformity Act

Bill Number

H.R. 7366

Origin Chamber

House

Congress

119th Congress, Session 2

Policy Area

Health

Status

Introduced

Latest Action

2026-02-04: Referred to the House Committee on Energy and Commerce.

Last Updated

2026-02-20T19:34:35Z

AI-Generated Summary

Purpose of the Legislation

The Dietary Supplement Regulatory Uniformity Act (H.R. 7366) aims to ensure consistent national regulation of dietary supplements by clarifying and strengthening the Food and Drug Administration's (FDA) authority to override conflicting state laws. This promotes uniformity in how dietary supplements—products like vitamins, minerals, herbs, or amino acids intended to supplement the diet—are regulated across the U.S.

Key Provisions

• Federal Preemption of State Requirements: No state or local government can impose rules on dietary supplements that differ from, add to, or are not identical to federal requirements under the Federal Food, Drug, and Cosmetic Act (FD&C Act). This applies to aspects like labeling, safety, or manufacturing standards.
• Exemption Process for States: States or localities can apply to the FDA for permission to enforce stricter rules if:
• The state rule is tougher than federal standards, or
• It addresses a specific urgent local issue (e.g., a regional health concern) without causing the supplement to violate federal law.
• The FDA must provide notice and a hearing before granting or denying exemptions through regulations.

Significant Changes to Existing Law

• Amends Section 403A of the FD&C Act (which previously focused on preemption for food labeling) by adding a new subsection (c) specifically for dietary supplements.
• Explicitly extends preemption to all dietary supplement requirements, closing potential gaps where states could previously create varying rules. This builds on the Dietary Supplement Health and Education Act of 1994, which already gave the FDA oversight but did not fully address state-federal conflicts.

Potential Impacts

• On Government Agencies: The FDA gains clearer authority to enforce national standards, potentially reducing administrative conflicts with states but increasing its workload for reviewing exemption requests.
• On Citizens: Consumers may benefit from consistent product availability and labeling nationwide, reducing confusion from varying state rules; however, it could limit state-specific protections against potentially harmful supplements.
• On International Relations: Minimal direct impact, though uniform U.S. standards could simplify trade for imported dietary supplements by aligning with federal oversight.

Main Stakeholders Affected

• Dietary Supplement Industry: Manufacturers and sellers gain predictability and lower compliance costs from uniform rules, easing interstate business.
• State and Local Governments: Lose flexibility to enact unique regulations, though they can seek exemptions for justified cases.
• Consumers and Health Advocates: Affected by standardized protections, which might streamline access but could hinder localized responses to emerging risks.
• FDA and Federal Regulators: Empowered with stronger enforcement tools to maintain oversight.

Notable Legal, Constitutional, or Political Implications

• Legal: Reinforces federal preemption under the Supremacy Clause of the U.S. Constitution, ensuring federal law trumps state law in regulating interstate commerce for dietary supplements. The exemption process provides a balanced mechanism to avoid overly broad overrides.
• Constitutional: Addresses federalism by centralizing authority at the federal level, potentially sparking debates over states' rights to protect public health.
• Political: Could appeal to industry groups seeking deregulation, while drawing criticism from consumer safety advocates or states favoring local control; no major partisan divide is evident in the bill's text.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Langworthy, Nicholas A. [R-NY-23]

Recent Actions

• 2026-02-04: Referred to the House Committee on Energy and Commerce.
• 2026-02-04: Introduced in House
• 2026-02-04: Introduced in House

Bill Versions

• Dietary Supplement Regulatory Uniformity Act — issued 2026-02-04 — PDF (2 pages)